ScoreWhy is Jilin Jian Yisheng Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -5.54% and Operating profit at -32.02% over the last 5 years
2
Flat results in Mar 26
- NET PROFIT(HY) At CNY 16.64 MM has Grown at -24.3%
- ROCE(HY) Lowest at 1.48%
- INTEREST(Q) At CNY 3.09 MM has Grown at 14.39%
3
With ROE of 1.56%, it has a fair valuation with a 0.61 Price to Book Value
- Over the past year, while the stock has generated a return of -19.78%, its profits have risen by 2.5% ; the PEG ratio of the company is 16
- At the current price, the company has a high dividend yield of 1.2
4
Below par performance in long term as well as near term
- Along with generating -19.78% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Jilin Jian Yisheng Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Jilin Jian Yisheng Pharmaceutical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Jilin Jian Yisheng Pharmaceutical Co., Ltd.
-11.45%
0.02
31.14%
China Shanghai Composite
0.9%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-5.54%
EBIT Growth (5y)
-32.02%
EBIT to Interest (avg)
4.62
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.26
Tax Ratio
4.45%
Dividend Payout Ratio
91.32%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.88%
ROE (avg)
3.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
58
Industry P/E
Price to Book Value
0.90
EV to EBIT
122.34
EV to EBITDA
39.35
EV to Capital Employed
0.89
EV to Sales
2.82
PEG Ratio
23.46
Dividend Yield
0.81%
ROCE (Latest)
0.73%
ROE (Latest)
1.56%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
RAW MATERIAL COST(Y)
Fallen by 0.38% (YoY
CASH AND EQV(HY)
Highest at CNY 1,259.49 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -6.36 %
-4What is not working for the Company
NET PROFIT(9M)
At CNY 27.72 MM has Grown at -20.32%
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.73 times
Here's what is working for Jilin Jian Yisheng Pharmaceutical Co., Ltd.
Cash and Eqv
Highest at CNY 1,259.49 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -6.36 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by 0.38% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Jilin Jian Yisheng Pharmaceutical Co., Ltd.
Debtors Turnover Ratio
Lowest at 2.73 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Net Profit
At CNY 27.72 MM has Grown at -20.32%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Footer loading
